Strikingly, mice with Ephrin A1-overexpressing cancer cells developed severe metastatic lesions, while erlotinib treatment strongly reduced the lung metastases of gastric cancer cells (Fig. 6B–E). This evidence concerns the gene EFNA1 and gastric cancer.